InvestSMART

Cochlear Limited (ASX:COH)

ALERT: Price-sensitive ASX Announcement for COH
Current share price for COH : $136.430 -109.21 (-44.46%)+
Announcement
Release
13 Feb 2026 7:34AM
Price at Release
$245.640
Full Release
download
Summary
Cochlear Limited's HY26 Result Presentation highlights financial performance, strategic priorities, and future outlook. The company reported a sales revenue of $1,176 million, a decrease of 2% in constant currency terms, and an underlying net profit down by 9% to $195 million. Cochlear's strategic focus includes expanding product availability, restructuring to enhance operational effectiveness, and addressing the needs of developed and emerging markets. The company anticipates a strong second half for FY26, driven by the availability of the Nexa System, growth in services, and improved acoustic segment momentum. Cochlear's mission remains to transform hearing loss treatment through innovation and global market leadership in implantable hearing solutions.
Key Points
  • Sales revenue was down 2% in constant currency terms.
  • Underlying net profit decreased by 9% to $195 million.
  • Plan to help over 60,000 people hear with implants in FY26.
  • Strong growth anticipated in developed markets in H2 FY26.
  • The transition to the Nucleus Nexa System is nearly complete.
  • Guidance based on FX rates with potential $30 million impact.
  • Strategic priorities focus on growth, market leadership, and sustainability.
  • Investment in research and development accounts for 12% of sales revenue.
  • Cochlear has a global presence with headquarters in Sydney, Australia.
  • The company aims for long-term sustainable growth and improved market access.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.